BioLife Solutions, Inc. (BLFS) Total liabilities 2017–2025
BioLife Solutions, Inc. (BLFS) total liabilities at each fiscal year-end, per SEC filings.
$34.0MFY2025 · since FY2017: $2.1M → $34.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $34.0M | -32.8% |
| FY2024 | $50.6M | -32.6% |
| FY2023 | $75.1M | -12.8% |
| FY2022 | $86.0M | +12.9% |
| FY2021 | $76.2M | +157.7% |
| FY2020 | $29.6M | -40.1% |
| FY2019 | $49.4M | +60.1% |
| FY2018 | $30.8M | +1403.4% |
| FY2017 | $2.1M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More BLFS financial trends
BLFS RevenueBLFS Net incomeBLFS Net marginBLFS Gross profitBLFS Gross marginBLFS Operating incomeBLFS Operating marginBLFS Operating cash flowBLFS Free cash flowBLFS Capital expendituresBLFS Return on equityBLFS Stock buybacksBLFS Dividends paidBLFS Total assetsBLFS Shareholders’ equityBLFS overview →